MNOV
NASD MediciNova, Inc.$1.54 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.54, $0.03 below the day’s high of $1.58
- YTD change
- +17.56%
- vs 20-day SMA
- -30.93%
- vs 200-day SMA
- +2.02%
Price ranges
Price & Performance
+0.10 (+6.94%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 90.4% away from all-time highs of $16.12
- MNOV is up 18% since the beginning of the year
- MNOV is up 22% over the past 12 months
- MNOV is down 15% over the past 1 month
- 0% of all MNOV investors are betting against MNOV
MNOV reads poor: price sits above one of the two key moving averages, the 12-month move is +24.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -13.48%
- vs 8-day SMA
- -6.38%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.